Capsid Antibodies to Different Adeno-Associated Virus Serotypes Bind Common Regions
Open accessThe DOI matches its Crossref record; 103 of the 104 references it cites were found in a registry or an index.
Abstract
Interactions between viruses and the host antibody immune response are critical in the development and control of disease, and antibodies are also known to interfere with the efficacy of viral vector-based gene delivery. The adeno-associated viruses (AAVs) being developed as vectors for corrective human gene delivery have shown promise in clinical trials, but preexisting antibodies are detrimental to successful outcomes. However, the antigenic epitopes on AAV capsids remain poorly characterized. Cryo-electron microscopy and three-dimensional image reconstruction were used to define the locations of epitopes to which monoclonal fragment antibodies (Fabs) against AAV1, AAV2, AAV5, and AAV6 bind. Pseudoatomic modeling showed that, in each serotype, Fabs bound to a limited number of sites near the protrusions surrounding the 3-fold axes of the T=1 icosahedral capsids. For the closely related AAV1 and AAV6, a common Fab exhibited substoichiometric binding, with one Fab bound, on average, between two of the three protrusions as a consequence of steric crowding. The other AAV Fabs saturated the capsid and bound to the walls of all 60 protrusions, with the footprint for the AAV5 antibody extending toward the 5-fold axis. The angle of incidence for each bound Fab on the AAVs varied and resulted in significant differences in how much of each viral capsid surface was occluded beyond the Fab footprints. The AAV-antibody interactions showed a common set of footprints that overlapped some known receptor-binding sites and transduction determinants, thus suggesting potential mechanisms for virus neutralization by the antibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“VR-VIII is part of an AAV2 antigenic epitope, and the difference is consistent with rAAV2.7m8’s escape from a known AAV2 monoclonal antibody, C37-B.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
The cited source says what the claim attributes to it.
In the citing paper
“This observation is consistent with the positioning of the peptide insert above at the epitope mapped for C37-B to VR-VIII using cryo-EM of the AAV2-C37-B complex (Fig. 8B) (Gurda et al., 2013).”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The rAAV2.7m8 insertion modified the C37-B antibody binding site (Gurda et al., 2013) creating an escape variant.”
From Structure comparison of the chimeric AAV2.7m8 vector with parental AAV2 (2020) · cites this paper as Gurda et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828 · cited 7×
“The fit-in-map function in Chimera was used to compare each AAV:Fab cryo-reconstruction to the corresponding map of the AAV:Fab model for quantitative assessment of the Fab docking.”
MethodInfluentialCoot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571 · cited 5×
“docked models in the program COOT (75), the absolute scale of each map”
InfluentialFeatures and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Inference of Macromolecular Assemblies from Crystalline State
Krissinel, E., & Henrick, K. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.05.022 · Cited by 9,984 · cited 5×
“(WAM) model of the 4E4 Fab, the PDBePISA application (84)”
BackgroundMethodInfluentialCryo-electron microscopy of vitrified specimens
Dubochet, J., Adrian, M., Chang, J.-J., Homo, J.-C., Lepault, J., McDowall, A. W., & Schultz, P. (1988) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583500004297 · Cited by 2,389 · cited 1×
“5 l) of AAV:Fab complexes were vitrified using standard rapid freeze-plunging procedures (64, 65).”
MethodManno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1358 · Cited by 2,163
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · cited 1×
“Each AAV serotype has a distinct ability to transduce cells and tissues of different hosts when the same transgene is packaged, indicating that the capsid itself dictates these differences (27, 37).”
BackgroundSummerford, C., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1438-1445.1998 · Cited by 1,406
Self-citationCryo-electron microscopy of viruses
Adrian, M., Dubochet, J., Lepault, J., & McDowall, A. W. (1984) · Nature · doi:10.1038/308032a0 · Cited by 1,342 · cited 1×
“5 l) of AAV:Fab complexes were vitrified using standard rapid freeze-plunging procedures (64, 65).”
MethodClades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues
Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., & Wilson, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6381-6388.2004 · Cited by 1,070 · cited 3×
“Furthermore, it is interesting that the A20 monoclonal, also an IgG3 (50), is reported to interact with similar regions on the AAV2 capsid (55), which is one of the most divergent serotypes from AAV5 (27).”
BackgroundAdenovirus-Associated Defective Virus Particles
Atchison, R. W., Casto, B. C., & Hammon, W. M. (1965) · Science · doi:10.1126/science.149.3685.754 · Cited by 1,004
Fourier shell correlation threshold criteria
van Heel, M., & Schatz, M. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.05.009 · Cited by 927
Visualizing density maps with UCSF Chimera
Goddard, T. D., Huang, C. C., & Ferrin, T. E. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.06.010 · Cited by 867 · cited 7×
“The fit-in-map function in Chimera was used to compare each AAV:Fab cryo-reconstruction to the corresponding map of the AAV:Fab model for quantitative assessment of the Fab docking.”
MethodInfluentialWorldwide epidemiology of neutralizing antibodies to adeno-associated viruses
Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J., & Wilson, J. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/595830 · Cited by 808
Immune responses to gene therapy vectors: influence on vector function and effector mechanisms
Bessis, N., GarciaCozar, F. J., & Boissier, M.-C. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302364 · Cited by 633
The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy
Xie, Q., Bu, W., Bhatia, S., Hare, J., Somasundaram, T., Azzi, A., & Chapman, M. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162250899 · Cited by 612 · cited 1×
“3NG9), AAV2 (PDB accession number 1LP3) (13), AAV5 (PDB accession”
Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors
Zolotukhin, S., Potter, M., Zolotukhin, I., Sakai, Y., Loiler, S., Fraites, T. J., Chiodo, V. A., Phillipsberg, T., Muzyczka, N., Hauswirth, W. W., et al. (2002) · Methods · doi:10.1016/s1046-2023(02)00220-7 · Cited by 565 · cited 1×
“following previously described protocols (62).”
Self-citationHoggan, M. D., Blacklow, N. R., & Rowe, W. P. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.55.6.1467 · Cited by 536
Bsoft: Image processing and molecular modeling for electron microscopy
Heymann, J. B., & Belnap, D. M. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.06.006 · Cited by 513 · cited 1×
“program (81), taking partial occupancy into account where relevant, and”
BackgroundBaker, T. S., Olson, N. H., & Fuller, S. D. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.862-922.1999 · Cited by 477
Self-citationBaker, T. S., Olson, N. H., & Fuller, S. D. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.1.237-237.2000 · Cited by 474
Self-citationRutledge, E. A., Halbert, C. L., & Russell, D. W. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.309-319.1998 · Cited by 452
Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., & Chiorini, J. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.6884-6893.2001 · Cited by 427
Self-citationGenetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
Girod, A., Ried, M., Wobus, C., Lahm, H., Leike, K., Kleinschmidt, J., Deléage, G., & Hallek, M. (1999) · Nature Medicine · doi:10.1038/12491 · Cited by 405
Identification of a heparin-binding motif on adeno-associated virus type 2 capsids
Kern, A., Schmidt, K., Leder, C., Müller, O. J., Wobus, C. E., Bettinger, K., Von der Lieth, C. W., King, J. A., & Kleinschmidt, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.20.11072-11081.2003 · Cited by 380 · cited 1×
“5B) (56, 57), and this is consistent with the reported receptor-blocking ability of the C37-B antibody (50).”
ResultOpie, S. R., Warrington, Agbandje-McKenna, M., Zolotukhin, S., & Muzyczka, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6995-7006.2003 · Cited by 364 · cited 1×
“5B) (56, 57), and this is consistent with the reported receptor-blocking ability of the C37-B antibody (50).”
ResultSelf-citationBinding of Adeno-associated Virus Type 5 to 2,3-Linked Sialic Acid Is Required for Gene Transfer
Walters, R. W., Yi, S. M. P., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., & Zabner, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101559200 · Cited by 363
Self-citationIdentification of PDGFR as a receptor for AAV-5 transduction
Pasquale, G. D., Davidson, B. L., Stein, C. S., Martins, I., Scudiero, D., Monks, A., & Chiorini, J. A. (2003) · Nature Medicine · doi:10.1038/nm929 · Cited by 355
Self-citationMulti-resolution contour-based fitting of macromolecular structures
Chacón, P., & Wriggers, W. (2002) · Journal of Molecular Biology · doi:10.1006/jmbi.2002.5438 · Cited by 336 · cited 8×
“The fit-in-map function in Chimera was used to compare each AAV:Fab cryo-reconstruction to the corresponding map of the AAV:Fab model for quantitative assessment of the Fab docking.”
BackgroundMethodInfluentialWu, Z., Miller, E., Agbandje-McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00895-06 · Cited by 328
Self-citationImmune Responses to AAV in Clinical Trials
Mingozzi, F., & A. High, K. (2011) · Current Gene Therapy · doi:10.2174/156652311796150354 · Cited by 324
Antiviral antibody responses: the two extremes of a wide spectrum
Hangartner, L., Zinkernagel, R. M., & Hengartner, H. (2006) · Nature Reviews Immunology · doi:10.1038/nri1783 · Cited by 314
Clinical gene therapy using recombinant adeno-associated virus vectors
Mueller, C., & Flotte, T. R. (2008) · Gene Therapy · doi:10.1038/gt.2008.68 · Cited by 313
Antibodies and B Cell Memory in Viral Immunity
Dörner, T., & Radbruch, A. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.002 · Cited by 290
Terminal N-Linked Galactose Is the Primary Receptor for Adeno-associated Virus 9
Shen, S., Bryant, K. D., Brown, S. M., Randell, S. H., & Asokan, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210922 · Cited by 282
Sonntag, F., Bleker, S., Leuchs, B., Fischer, R., & Kleinschmidt, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.01056-06 · Cited by 280 · cited 1×
“A small number of mouse monoclonal antibodies (MAbs) have been examined that recognize AAV2 capsids (50) and have been raised against other serotypes (10, 51, 52).”
BackgroundWobus, C. E., Hügle-Dörr, B., Girod, A., Petersen, G., Hallek, M., & Kleinschmidt, J. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9281-9293.2000 · Cited by 273 · cited 10×
“Mutation of these residues caused a partial reversal of C37-B MAb competition (50).”
BackgroundMethodResultInfluentialKleywegt, G. J., & Jones, T. A. (1996) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444995014983 · Cited by 271
Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector
Nam, H.-J., Lane, M. D., Padron, E., Gurda, B., McKenna, R., Kohlbrenner, E., Aslanidi, G., Byrne, B., Muzyczka, N., Zolotukhin, S., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01304-07 · Cited by 255
Self-citationMoskalenko, M., Chen, L., van Roey, M., Donahue, B. A., Snyder, R. O., McArthur, J. G., & Patel, S. D. (2000) · Journal of Virology · doi:10.1128/jvi.74.4.1761-1766.2000 · Cited by 253
Mori, S., Wang, L., Takeuchi, T., & Kanda, T. (2004) · Virology · doi:10.1016/j.virol.2004.10.012 · Cited by 245
Immune Responses to AAV in Clinical Trials
Mingozzi, F., & High, K. (2007) · Current Gene Therapy · doi:10.2174/156652307782151425 · Cited by 238
Wu, Z., Asokan, A., Grieger, J. C., Govindasamy, L., Agbandje-McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.01288-06 · Cited by 237 · cited 2×
“Furthermore, 4E4 binding across the 2-fold axes occludes access to E531/ K531 in AAV1/AAV6, respectively, and K531 is known to be involved in HSPG binding by AAV6 (58).”
BackgroundSelf-citationAntibody Elbow Angles are Influenced by their Light Chain Class
Stanfield, R. L., Zemla, A., Wilson, I. A., & Rupp, B. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.01.023 · Cited by 233 · cited 13×
“3C5 (3C5) IgGs were determined by reverse transcriptase PCR using various combinations of mouse IgG-specific primers.”
BackgroundInfluentialHalbert, C. L., Miller, A. D., Mcnamara, S., Emerson, J., Gibson, R. L., Ramsey, B., & Aitken, M. L. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.440 · Cited by 227 · cited 1×
“A small study of 129 people suffering from cystic fibrosis and 37 unaffected individuals showed that 20 to 30% were seropositive for AAV6 and that 10 to 20% were seropositive for AAV5 (40).”
BackgroundPeden, C. S., Burger, C., Muzyczka, N., & Mandel, R. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.12.6344-6359.2004 · Cited by 222
Self-citationSubcellular compartmentalization of adeno-associated virus type 2 assembly
Wistuba, A., Kern, A., Weger, S., Grimm, D., & Kleinschmidt, J. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.1341-1352.1997 · Cited by 219 · cited 10×
“9116 jvi.asm.org Journal of Virology on July 22, 2018 by guest http://jvi.asm .org/ D ow nloaded from Notably, the region identified within VR-VIII contains two critical arginines, R585 and R588, both of which are important in AAV2 binding to the HSPG receptor (Fig.”
ResultInfluentialAAV Capsid Structure and Cell Interactions
Agbandje-McKenna, M., & Kleinschmidt, J. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-370-7_3 · Cited by 215
Self-citationWang, L., Calcedo, R., Bell, P., Lin, J., Grant, R. L., Siegel, D. L., & Wilson, J. M. (2011) · Human Gene Therapy · doi:10.1089/hum.2011.031 · Cited by 212
Structurally mapping the diverse phenotype of adeno-associated virus serotype 4
Govindasamy, L., Padron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., & Agbandje-McKenna, M. (2006) · Journal of Virology · doi:10.1128/jvi.01536-06 · Cited by 205 · cited 7×
“The adeno-associated viruses (AAVs) being developed as vectors for corrective human gene delivery have shown promise in clinical trials, but preexisting antibodies are detrimental to successful outcomes.”
BackgroundInfluentialSelf-citationThe influence of virus structure on antibody responses and virus serotype formation
Bachmann, M. F., & Zinkernagel, R. M. (1996) · Immunology Today · doi:10.1016/s0167-5699(96)10066-9 · Cited by 204
Lochrie, M. A., Tatsuno, G. P., Christie, B., McDonnell, J. W., Zhou, S., Surosky, R., Pierce, G. F., & Colosi, P. (2006) · Journal of Virology · doi:10.1128/jvi.80.2.821-834.2006 · Cited by 201 · cited 1×
“While verification of site B as the CDR binding epitope is required, it is interesting that these residues are located in capsid locations similar to the epitope footprint mapped for the A20 antibody against AAV2 (50, 55, 89).”
BackgroundModeling antibody hypervariable loops: a combined algorithm.
Martin, A. C., Cheetham, J. C., & Rees, A. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9268 · Cited by 196 · cited 1×
“The more diverse, noncanonical regions were built using the combined antibody modeling algorithm (CAMAL) (63).”
MethodCharacterization of the DNA of a defective human parvovirus isolated from a genital site
Bantel-Schaal, U., & Zur Hausen, H. (1984) · Virology · doi:10.1016/0042-6822(84)90271-x · Cited by 188
Limberis, M. P., Vandenberghe, L. H., Zhang, L., Pickles, R. J., & Wilson, J. M. (2009) · Molecular Therapy · doi:10.1038/mt.2008.261 · Cited by 184 · cited 1×
“One of the proposed 5H7 contact peptides, 588-STDPATGD-595, maps structurally close to the positions of two (aa 584 and 598) of the six residues that distinguish the AAV1 and AAV6 capsid VP subunits and, along with residue 531, are reported to influence tissue transduction differences between these two AAV serotypes (…”
BackgroundAUTO3DEM—an automated and high throughput program for image reconstruction of icosahedral particles
Yan, X., Sinkovits, R. S., & Baker, T. S. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.08.007 · Cited by 183 · cited 3×
“The AUTO3DEM program (67) was used as previously described (68) to generate an initial, low-resolution ( 30 Å) 3D reconstruction of each complex from a set of 150 particle images using the random-model computation procedure (69).”
MethodSelf-citationAsokan, A., Hamra, J. B., Govindasamy, L., Agbandje-McKenna, M., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.00843-06 · Cited by 183
Self-citationDirected evolution of adeno-associated virus to an infectious respiratory virus
Excoffon, K. J. D. A., Koerber, J. T., Dickey, D. D., Murtha, M., Keshavjee, S., Kaspar, B. K., Zabner, J., & Schaffer, D. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813365106 · Cited by 181
Immunity to adeno-associated virus vectors in animals and humans: a continued challenge
Zaiss, A. K., & Muruve, D. A. (2008) · Gene Therapy · doi:10.1038/gt.2008.54 · Cited by 180
The galactan‐binding immunoglobulin Fab J539: An x‐ray diffraction study at 2.6‐Å resolution
Suh, S. W., Bhat, T. N., Navia, M. A., Cohen, G. H., Rao, D. N., Rudikoff, S., & Davies, D. R. (1986) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340010112 · Cited by 173 · cited 2×
“(PDB 2FBJ (IgA) (77), 8FAB (IgG1) (78), and 1ETZ (IgG2B) (79) to assess”
MethodGrieger, J. C., Snowdy, S., & Samulski, R. J. (2006) · Journal of Virology · doi:10.1128/jvi.02723-05 · Cited by 172
Self-citationSchmidt, M., Voutetakis, A., Afione, S., Zheng, C., Mandikian, D., & Chiorini, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.02012-07 · Cited by 165 · cited 1×
“To date, the genetic variants AAV10 and AAV11 (28), AAV12 (29), and AAV VR-942 (36) have not been serologically characterized.”
BackgroundSelf-citationReovirus polymerase λ3 localized by cryo-electron microscopy of virions at a resolution of 7.6 Å
Zhang, X., Walker, S. B., Chipman, P. R., Nibert, M. L., & Baker, T. S. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb1009 · Cited by 162
Self-citationStructural Characterization of the Dual Glycan Binding Adeno-Associated Virus Serotype 6
Ng, R., Govindasamy, L., Gurda, B. L., McKenna, R., Kozyreva, O. G., Samulski, R. J., Parent, K. N., Baker, T. S., & Agbandje-McKenna, M. (2010) · Journal of Virology · doi:10.1128/jvi.01235-10 · Cited by 143 · cited 2×
“number 3NTT), and AAV6 (PDB accession number 30AH) (16) were”
BackgroundSelf-citationStahnke, S., Lux, K., Uhrig, S., Kreppel, F., Hösel, M., Coutelle, O., Ogris, M., Hallek, M. J., & Büning, H. (2010) · Virology · doi:10.1016/j.virol.2010.09.025 · Cited by 142
Interpretation of electron density with stereographic roadmap projections
Xiao, C., & Rossmann, M. G. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.10.013 · Cited by 140 · cited 1×
“The isodensity for each virus-Fab complex is shown (left column) with the antigenic epitopes depicted on a roadmap (103) (right column).”
BackgroundAdeno-associated virus-2 and its primary cellular receptor—Cryo-EM structure of a heparin complex
O'Donnell, J., Taylor, K. A., & Chapman, M. S. (2009) · Virology · doi:10.1016/j.virol.2008.11.037 · Cited by 125
Huttner, N. A., Girod, A., Perabo, L., Edbauer, D., Kleinschmidt, J. A., Büning, H., & Hallek, M. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302123 · Cited by 124 · cited 1×
“Mutational analysis, peptide insertions and deletions, and linear epitope mapping methods have been used to characterize the binding of MAbs to AAV2 (50, 53).”
MethodHuman Bocavirus Capsid Structure: Insights into the Structural Repertoire of the Parvoviridae
Gurda, B. L., Parent, K. N., Bladek, H., Sinkovits, R. S., DiMattia, M. A., Rence, C., Castro, A., McKENNA, R. V., Olson, N. H., Brown, K. E., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02719-09 · Cited by 117 · cited 1×
“program (67) was used as previously described (68) to generate an initial, low-resolution ( 30 Å) 3D reconstruction of each complex from a set of 150 particle images using the random-model computation procedure (69).”
MethodSelf-citationXiao, W., Chirmule, N., Schnell, M. A., Tazelaar, J., Hughes, J. V., & Wilson, J. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0045 · Cited by 114
Heparin binding induces conformational changes in Adeno-associated virus serotype 2
Levy, H. C., Bowman, V. D., Govindasamy, L., McKenna, R., Nash, K., Warrington, K., Chen, W., Muzyczka, N., Yan, X., Baker, T. S., et al. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2008.12.002 · Cited by 110
Self-citationLerch, T. F., Xie, Q., & Chapman, M. S. (2010) · Virology · doi:10.1016/j.virol.2010.03.027 · Cited by 106
Dobrzynski, E., Fitzgerald, J. C., Cao, O., Mingozzi, F., Wang, L., & Herzog, R. W. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508685103 · Cited by 105
Neutralization of animal virus infectivity by antibody
Reading, S. A., & Dimmock, N. J. (2007) · Archives of Virology · doi:10.1007/s00705-006-0923-8 · Cited by 105 · cited 1×
“These include the following: (i) competition for receptor attachment sites, (ii) abrogation of postentry events during endosomal trafficking, and (iii) stabilization of the capsid against structural changes required for uncoating within the cell (8, 87, 91).”
BackgroundAb initio random model method facilitates 3D reconstruction of icosahedral particles
Yan, X., Dryden, K. A., Tang, J., & Baker, T. S. (2006) · Journal of Structural Biology · doi:10.1016/j.jsb.2006.07.013 · Cited by 96 · cited 1×
“program (67) was used as previously described (68) to generate an initial, low-resolution ( 30 Å) 3D reconstruction of each complex from a set of 150 particle images using the random-model computation procedure (69).”
MethodSelf-citationCloning of an Avian Adeno-Associated Virus (AAAV) and Generation of Recombinant AAAV Particles
Bossis, I., & Chiorini, J. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6799-6810.2003 · Cited by 93
Self-citationMapping a Neutralizing Epitope onto the Capsid of Adeno-Associated Virus Serotype 8
Gurda, B. L., Raupp, C., Popa-Wagner, R., Naumer, M., Olson, N. H., Ng, R., McKenna, R., Baker, T. S., Kleinschmidt, J. A., & Agbandje-McKenna, M. (2012) · Journal of Virology · doi:10.1128/jvi.00218-12 · Cited by 93 · cited 17×
“9116 jvi.asm.org Journal of Virology on July 22, 2018 by guest http://jvi.asm .org/ D ow nloaded from Notably, the region identified within VR-VIII contains two critical arginines, R585 and R588, both of which are important in AAV2 binding to the HSPG receptor (Fig.”
BackgroundInfluentialSelf-citationLi, W., Zhang, L., Johnson, J. S., Zhijian, W., Grieger, J. C., Ping-Jie, X., Drouin, L. M., Agbandje-McKenna, M., Pickles, R. J., & Samulski, R. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.155 · Cited by 87 · cited 1×
“One of the proposed 5H7 contact peptides, 588-STDPATGD-595, maps structurally close to the positions of two (aa 584 and 598) of the six residues that distinguish the AAV1 and AAV6 capsid VP subunits and, along with residue 531, are reported to influence tissue transduction differences between these two AAV serotypes (…”
BackgroundSelf-citationStructure of adeno-associated virus-2 in complex with neutralizing monoclonal antibody A20
McCraw, D. M., O’Donnell, J. K., Taylor, K. A., Stagg, S. M., & Chapman, M. S. (2012) · Virology · doi:10.1016/j.virol.2012.05.004 · Cited by 84 · cited 3×
“Furthermore, it is interesting that the A20 monoclonal, also an IgG3 (50), is reported to interact with similar regions on the AAV2 capsid (55), which is one of the most divergent serotypes from AAV5 (27).”
BackgroundStructural Comparison of Different Antibodies Interacting with Parvovirus Capsids
Hafenstein, S., Bowman, V. D., Sun, T., Nelson, C. D. S., Palermo, L. M., Chipman, P. R., Battisti, A. J., Parrish, C. R., & Rossmann, M. G. (2009) · Journal of Virology · doi:10.1128/jvi.02532-08 · Cited by 81 · cited 1×
“For example, the cylinder-shaped surface feature that surrounds each 5-fold axis of symmetry in the AAV capsids did not bind antibodies, and the same features in CPV and FPV capsids also did not bind any of the eight antibodies that have been examined (86).”
BackgroundSelf-citationStrong, R. K., Campbell, R. L., Rose, D. R., Petsko, G. A., Sharon, J., & Margolies, M. N. (1991) · Biochemistry · doi:10.1021/bi00229a022 · Cited by 79
Cottard, V., Valvason, C., Falgarone, G., Lutomski, D., Boissier, M., & Bessis, N. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000019781.64421.5c · Cited by 77
Development of AAV serotype-specific ELISAs using novel monoclonal antibodies
Kuck, D., Kern, A., & Kleinschmidt, J. A. (2007) · Journal of Virological Methods · doi:10.1016/j.jviromet.2006.10.005 · Cited by 74 · cited 1×
“A small number of mouse monoclonal antibodies (MAbs) have been examined that recognize AAV2 capsids (50) and have been raised against other serotypes (10, 51, 52).”
BackgroundSchmidt, M., Govindasamy, L., Afione, S., Kaludov, N., Agbandje-McKenna, M., & Chiorini, J. A. (2008) · Journal of Virology · doi:10.1128/jvi.00672-08 · Cited by 74
Self-citationArbetman, A. E., Lochrie, M., Zhou, S., Wellman, J., Scallan, C., Doroudchi, M. M., Randlev, B., Patarroyo-White, S., Liu, T., Smith, P., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15238-15245.2005 · Cited by 71
Structure–function analysis of receptor-binding in adeno-associated virus serotype 6 (AAV-6)
Xie, Q., Lerch, T. F., Meyer, N. L., & Chapman, M. S. (2011) · Virology · doi:10.1016/j.virol.2011.08.011 · Cited by 70
Vandenberghe, L., & Wilson, J. (2007) · Current Gene Therapy · doi:10.2174/156652307782151416 · Cited by 68
A parvovirus isolated from royal python (Python regius) is a member of the genus Dependovirus
Farkas, S. L., Zádori, Z., Benkő, M., Essbauer, S., Harrach, B., & Tijssen, P. (2004) · Journal of General Virology · doi:10.1099/vir.0.19616-0 · Cited by 67
Identification and Characterization of Novel Adeno-Associated Virus Isolates in ATCC Virus Stocks
Schmidt, M., Grot, E., Cervenka, P., Wainer, S., Buck, C., & Chiorini, J. A. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5082-5085.2006 · Cited by 60
Self-citationPhysicochemical Characterization of Adeno-associated Satellite Virus Type 4 and Its Nucleic Acid
Parks, W. P., Green, M., Piña, M., & Melnick, J. L. (1967) · Journal of Virology · doi:10.1128/jvi.1.5.980-987.1967 · Cited by 58
Miller, E. B., Gurda-Whitaker, B., Govindasamy, L., McKenna, R., Zolotukhin, S., Muzyczka, N., & Agbandje-McKenna, M. (2006) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309106048184 · Cited by 58
Self-citationBowman, V. D., Chase, E. S., Franz, A. W. E., Chipman, P. R., Zhang, X., Perry, K. L., Baker, T. S., & Smith, T. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12250-12258.2002 · Cited by 55
Self-citationHarbison, C. E., Weichert, W. S., Gurda, B. L., Chiorini, J. A., Agbandje-McKenna, M., & Parrish, C. R. (2012) · Journal of General Virology · doi:10.1099/vir.0.035113-0 · Cited by 54
Self-citationAntibodies against viruses: passive and active immunization
Law, M., & Hangartner, L. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.005 · Cited by 48 · cited 1×
“These include the following: (i) competition for receptor attachment sites, (ii) abrogation of postentry events during endosomal trafficking, and (iii) stabilization of the capsid against structural changes required for uncoating within the cell (8, 87, 91).”
BackgroundLi, H., Lin, S.-W., Giles-Davis, W., Li, Y., Zhou, D., Xiang, Z. Q., High, K. A., & Ertl, H. C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.79 · Cited by 46 · cited 1×
“For example, examination of AAV-specific memory T and B cells in mice showed that the reduction in virus transduction was primarily caused by AAVbinding antibodies, which were partially cross-reactive and did not specifically require AAV-neutralizing antibodies, CD8 T cells, natural killer (NK) cells, or natural kille…”
BackgroundDiMattia, M., Govindasamy, L., Levy, H. C., Gurda-Whitaker, B., Kalina, A., Kohlbrenner, E., Chiorini, J. A., McKenna, R., Muzyczka, N., Zolotukhin, S., et al. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105028514 · Cited by 42
Self-citationHow not to be seen: immune-evasion strategies in gene therapy
Zaldumbide, A., & Hoeben, R. C. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303082 · Cited by 38
Kaufmann, B., López-Bueno, A., Mateu, M. G., Chipman, P. R., Nelson, C. D. S., Parrish, C. R., Almendral, J. M., & Rossmann, M. G. (2007) · Journal of Virology · doi:10.1128/jvi.00775-07 · Cited by 34
Self-citationGuddat, L. W., Lin, S., Broomell, C. C., Ramsland, P. A., Fan, Z.-C., Anchin, J. M., Linthicum, D. S., & Edmundson, A. B. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4083 · Cited by 27 · cited 1×
“(PDB 2FBJ (IgA) (77), 8FAB (IgG1) (78), and 1ETZ (IgG2B) (79) to assess”
Dutta, S. K. (1975) · American Journal of Veterinary Research · doi:10.2460/ajvr.1975.36.03.247 · Cited by 25
The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen
Brooks, C. L., Blackler, R. J., Sixta, G., Kosma, P., Müller‐Loennies, S., Brade, L., Hirama, T., MacKenzie, C. R., Brade, H., & Evans, S. V. (2009) · Glycobiology · doi:10.1093/glycob/cwp150 · Cited by 23 · cited 1×
“Fitting for the 3C5 Fab (bound to AAV5) density involved using a similar IgG isotype, IgG3 (PDB 3IJH) (83), and manually docking the four regions (heavy and light chains and variable and constant regions) into the Fab density.”
MethodStructural Studies on Antibody–Virus Complexes
Smith, T. J. (2003) · Advances in protein chemistry · doi:10.1016/s0065-3233(03)01012-x · Cited by 9 · cited 1×
“These include the following: (i) competition for receptor attachment sites, (ii) abrogation of postentry events during endosomal trafficking, and (iii) stabilization of the capsid against structural changes required for uncoating within the cell (8, 87, 91).”
Background
Research works printed but not linked: 2
- 18. Chapman MS, Agbandje-McKenna M. 2006. Atomic structures of viral particles, p 107–123 In Kerr JR, Cotmore SF, Bloom ME, Linden RL, Parrish CR. (ed), Parvoviruses. Edward Arnold, Ltd., New York, NY [Google Scholar]
- 19. Agbandje-McKenna M, Chapman MS. 2006. Corrleating structure with function in the viral capsid, p 125–139 In Kerr JR, Cotmore SF, Bloom ME, Linden RM, Parrish CR. (ed), Parvoviruses. Edward Arnold, Ltd., New York, NY [Google Scholar]
Cited by
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444
In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector
Zinn, E., Pacouret, S., Khaychuk, V., Turunen, H. T., Carvalho, L. S., Andres-Mateos, E., Shah, S., Shelke, R., Maurer, A. C., Plovie, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.019 · Cited by 310
“(Mingozzi et al., 2007) Mouse B-cell epitopes of defined AAV2 antibody SADNNNS plus RGNRQ for C37B Fab (Gurda et al., 2013).”
BackgroundCapsid modifications for targeting and improving the efficacy of AAV vectors
Büning, H., & Srivastava, A. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.01.008 · Cited by 260
“Topological prominent capsid surface structures are pores or “channel-like-structures” at each fivefold, depressions at each twofold, and three protrusions surrounding each threefold axis of symmetry.(37) The pores allow exchange between the capsid interior and the outside.”
BackgroundBucher, K., Rodríguez-Bocanegra, E., Dauletbekov, D., & Fischer, M. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100915 · Cited by 242
Tse, L. V., Klinc, K. A., Madigan, V. J., Castellanos Rivera, R. M., Wells, L. F., Havlik, L. P., Smith, J. K., Agbandje-McKenna, M., & Asokan, A. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1704766114 · Cited by 210
“Here we tested this hypothesis using AAV1 as a template, which we chose because of the availability of extensive structural information pertaining to this capsid complexed with different mAbs and its cognate glycan receptor, sialic acid (SA) (9, 10, 16).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Gurda, B. L., DiMattia, M. A., Miller, E. B., Bennett, A., McKenna, R., Weichert, W. S., Nelson, C. D., Chen, W.-J., Muzyczka, N., Olson, N. H., Sinkovits, R. S., Chiorini, J. A., Zolotutkhin, S., Kozyreva, O. G., Samulski, R. J., Baker, T. S., Parrish, C. R., & Agbandje-McKenna, M.
- Affiliations
- University of Florida (US)
- Cornell University (US)
- University of California San Diego (US)
- National Institutes of Health (US)
- University of North Carolina at Chapel Hill (US)
- Deptartment of Biochemistry and Molecular Biology, University of Florida, Gainesville, Florida, USA
- ORCID
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2013-08-15
- Volume
- 87
- Issue
- 16
- Pages
- 9111-9124
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC3754064
- OpenAlex
- W2171084404
- Cited by
- 127
- References
- 104
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 15 · 2020: 14 · 2019: 15 · 2018: 13 · 2017: 8 · 2016: 5 · 2015: 9 · 2014: 9 · 2013: 4
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Virology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (4r37gm033050-27)
- University of California, San Diego
- National Heart, Lung, and Blood Institute (P01HL112761)
- National Institute of General Medical Sciences (R37GM-033050, R37 GM-33050, R01GM082946)
- National Institute of Allergy and Infectious Diseases (R01AI072176, R21AI072341)
- National Center for Research Resources (S10RR020016)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- adeno-associated virus, AAV capsid, antibody epitopes, AAV serotypes, AAV1, AAV2, AAV5, AAV6, steric crowding, virus neutralization, gene therapy vectors, receptor binding sites
- MeSH terms
- Dependovirus, Antibodies, Monoclonal, Antibodies, Viral, Epitopes, Binding Sites, Capsid, Humans, Models, Molecular, Protein Binding, Cryoelectron Microscopy, Imaging, Three-Dimensional, Macromolecular Substances
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.